Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CSG shares surge in Amsterdam debut

(Sharecast News) - Shares in Prague-based defence firm CSG surged on their debut on Amsterdam's Euronext on Friday, in what was the largest defence‑sector initial public offering, both in terms of funds raised and market capitalisation. CSG jumped as much as 32% at one point as investors continued to pile into the sector amid Europe's push to bolster military capability.

The Czech company, which produces armoured vehicles, ammunition and advanced defence systems, raised €3.8bn in its initial public offering.

The listing comes against a backdrop of heightened geopolitical tension, following weeks of uncertainty after Donald Trump threatened to use military force to seize Greenland from Denmark, a NATO ally.

Michael Strnad, CSG's owner, who was expected to receive roughly €3bn from the deal, said: "Today marks a historic milestone for CSG as we join the Euronext Amsterdam market and we welcome the confidence shown in us by investors.

"Becoming a publicly listed company demonstrates our commitment to high standards of transparency, disclosure and corporate governance and strengthens our ability to invest in innovation, expand our global reach and deliver on our mission to be a critical long-term supplier of advanced defence and industrial solutions to NATO states and Government partners worldwide."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

JP Morgan raises target price on GSK
(Sharecast News) - Analysts at JP Morgan raised their target price on drugmaker GSK to £22.50 on Monday on improving investor perception.
Kroger appoints former Walmart executive Greg Foran as CEO
(Sharecast News) - US supermarket retailer Kroger said on Monday that it has appointed former Walmart executive Greg Foran as chief executive officer with immediate effect.
Avacta finds new science chief internally
(Sharecast News) - Avacta Therapeutics announced the appointment of Francis Wilson as its chief scientific officer on Monday, effective immediately, as the AIM-traded clinical-stage biopharmaceutical company prepared for further development of its 'preCISION' tumour-activated oncology delivery platform.
UniCredit raises medium-term targets after bumper year
(Sharecast News) - UniCredit reported record full-year results for 2025 on Monday and raised its medium-term profit and distribution targets, as earnings from strategic equity stakes and resilient fee income offset pressure from lower interest rates and one-off costs, prompting a strong positive market reaction.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.